# US 9,750,876 B2 · Infusion site leak detection device > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 9,750,876 B2 - Document ID: US9750876B2 - Status: Granted - Kind: B2 - Application number: 14/045,261 - Filed: 2013-10-03 - Published: 2014-04-10 - Granted: 2017-09-05 - Earliest claimed: 2012-10-09 - Assignees: Becton, Dickinson and Company - Applicants: Becton, Dickinson and Company - Inventors: Weiyan Nie; Zhixiong Liu - Web page: https://patentgrep.com/patent/US9750876B2 ## CPC - A61M 5/16831: {Monitoring, detecting, signalling or eliminating infusion flow anomalies (low-level float-valves causing cut-off A61M5/40; indicating or recording presence, absence or direction of flow in general G01P13/0066)} - A61M 5/158: Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body} - A61P 3/10: for hyperglycaemia, e.g. antidiabetics - A61M 2005/1588: {having means for monitoring, controlling or visual inspection, e.g. for patency check or for avoiding extravasation} - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract An infusion set or patch pump is provided for delivering a pharmaceutical agent, such as insulin, to a patient. The infusion set or patch pump has a recessed portion in the bottom face containing a hydrogel and a reactant capable of producing a color change upon contact with the pharmaceutical agent. The reactant includes a mixture of potassium persulfate and 4-aminoantipyrine and optionally horseradish peroxidase, and produces a rapid visually detectable color change when contacted with phenol and/or m-cresol contained in insulin as stabilizing agents. ## Claims ### Claim 1 A fluid delivery device for introducing a fluid to a patient, comprising: a fluid supply for delivering a fluid containing an active agent and at least one stabilizing or preserving agent; and a delivery device adapted for delivering the fluid to the patient, the delivery device having a base having a bottom face with an adhesive for attaching to the skin of the patient, a hub having a bottom surface for contacting the skin of the patient, a cavity formed in said hub and recessed with respect to said bottom surface of said hub, and a cannula for penetrating the skin of a patient and oriented within said cavity of said hub, and a hydrogel positioned in said cavity of said hub and surrounding said cannula and spaced inwardly from said adhesive, said hydrogel containing a leak detector including potassium persulfate and 4-amino-antipyrine in an amount sufficient to react with the stabilizing or preserving agent in the fluid and produce a visible color change that is visible through said hub when the leak detector contacts the fluid, and where said adhesive surrounds said hub and cavity to capture leakage of the fluid from an injection site within said cavity. ### Claim 2 (depends on 1) The fluid delivery device of claim 1, wherein said hydrogel is attached to said hub by an adhesive at a delivery site. ### Claim 3 (depends on 1) The fluid delivery device of claim 1, wherein said hub has at least one substantially transparent portion to visualize the color change. ### Claim 4 (depends on 1) The fluid delivery device of claim 1, wherein said active agent comprises insulin and said at least one stabilizing agent is selected from the group consisting of m-cresol, phenol, and mixtures thereof. ### Claim 5 (depends on 1) The fluid delivery device of claim 1, wherein said hydrogel further comprises an effective amount of horseradish peroxidase to catalyze the reaction. ### Claim 6 An insulin delivery device, comprising: an insulin supply source for delivering a fluid containing insulin and at least one phenolic stabilizing agent; and an infusion set having an interface having a cavity and a contact area with a contact face surrounding said cavity with an adhesive for contacting and attaching directly to the skin of the patient, the interface having a cannula in said cavity adapted for penetrating the skin of a patient, said cavity surrounding the cannula to capture insulin leakage from the cannula at the infusion site, a leak detector positioned in the cavity surrounding the cannula and recessed with respect to said contact face, said leak detector including a hydrogel containing potassium persulfate and 4-aminoantipyrine in an amount effective to produce a visible color change when contacted with the stabilizing agent that is visible through said infusion set. ### Claim 7 (depends on 6) The insulin delivery device of claim 6, wherein said at least one stabilizing agent is selected from the group consisting of m-cresol, phenol, and mixtures thereof. ### Claim 8 (depends on 6) The insulin delivery device of claim 6, wherein said leak detector further comprises an effective amount of horseradish peroxidase to catalyze the reaction between the potassium persulfate, 4-aminoantipyrine and the stabilizing agent. ### Claim 9 (depends on 6) The insulin delivery device of claim 6, wherein said hydrogel is attached to said interface by an adhesive. ### Claim 10 An insulin delivery device, comprising: an insulin supply source for delivery of an infusion liquid containing insulin; and an infusion set coupled to said supply source, said infusion set having a base with an interface for attaching to the skin of a patient, a hub coupled to said base where at least a portion of said hub is substantially transparent, said hub having an annular recess with an inner wall defining a cavity formed in the hub, a cannula coupled to said hub and positioned in said cavity and adapted for penetrating the skin of the patient, and a leakage detector within said cavity of said hub and surrounding said cannula, said leakage detector having at least one reactant capable of undergoing a color change upon contact with at least one constituent in said infusion liquid and being visible through said base, wherein said leakage detector comprises a hydrogel containing potassium persulfate, 4-aminoantipyrine and horseradish peroxidase, and where said hydrogel is contained in said cavity of said base surrounding said cannula and spaced from said cannula a distance to define an open area to capture said infusion liquid leaking from an infusion site in said cavity of said hub and where said color change is visible through said hub. ### Claim 11 (depends on 1) The fluid delivery device of claim 1, wherein said hydrogel is positioned between an inner wall of said cavity in said hub and said cannula to define a cavity a between said hydrogel and said cannula to capture leakage of the fluid from the injection site.